165 related articles for article (PubMed ID: 7655155)
1. [Antisense nucleic acids and gene therapy].
Saison-Behmoaras E
Bull Cancer; 1995 Mar; 82(3):224-5. PubMed ID: 7655155
[No Abstract] [Full Text] [Related]
2. Making sense of antisense.
Murakami A
Trends Mol Med; 2001 Oct; 7(10):430-1. PubMed ID: 11597507
[No Abstract] [Full Text] [Related]
3. Control of oncogene expression by antisense nucleic acids.
Hélène C
Eur J Cancer; 1994; 30A(11):1721-6. PubMed ID: 7833151
[No Abstract] [Full Text] [Related]
4. Suppression of pancreatic and colon cancer cells by antisense K-ras RNA expression vectors.
Aoki K; Ohnami S; Yoshida T
Methods Mol Med; 2005; 106():193-204. PubMed ID: 15375317
[No Abstract] [Full Text] [Related]
5. Selective gene therapy for proliferative disorders: sense and antisense.
Indolfi C; Chiariello M; Avvedimento EV
Nat Med; 1996 Jun; 2(6):634-5. PubMed ID: 8640548
[No Abstract] [Full Text] [Related]
6. Antisense oligonucleotides and the rational design of new antitumor drugs.
Prieto J; Hernández-Alcoceba R
Rev Esp Enferm Dig; 2005 Jul; 97(7):467-71. PubMed ID: 16262525
[No Abstract] [Full Text] [Related]
7. Targeting Long Noncoding RNA with Antisense Oligonucleotide Technology as Cancer Therapeutics.
Zhou T; Kim Y; MacLeod AR
Methods Mol Biol; 2016; 1402():199-213. PubMed ID: 26721493
[TBL] [Abstract][Full Text] [Related]
8. Manipulation of renal gene expression using oligonucleotides.
Lakhia R; Mishra A; Patel V
Methods Cell Biol; 2019; 154():109-120. PubMed ID: 31493813
[TBL] [Abstract][Full Text] [Related]
9. Clinical development of antisense oligonucleotides as anti-cancer therapeutics.
Chen HX
Methods Mol Med; 2003; 75():621-36. PubMed ID: 12407768
[No Abstract] [Full Text] [Related]
10. Antisense oligonucleotides in cancer.
Castanotto D; Stein CA
Curr Opin Oncol; 2014 Nov; 26(6):584-9. PubMed ID: 25188471
[TBL] [Abstract][Full Text] [Related]
11. Pharmacologic inactivation of kinase suppressor of ras-1 abrogates Ras-mediated pancreatic cancer.
Xing HR; Cordon-Cardo C; Deng X; Tong W; Campodonico L; Fuks Z; Kolesnick R
Nat Med; 2003 Oct; 9(10):1266-8. PubMed ID: 12960962
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic applications of antisense oligonucleotides in asthma and allergy.
Isidoro-García M; Dávila I
Recent Pat Inflamm Allergy Drug Discov; 2007 Nov; 1(3):171-5. PubMed ID: 19075979
[TBL] [Abstract][Full Text] [Related]
13. The approach of triple helix formation in control of gene expression and the treatment of tumors expressing IGF-I.
Upegui-Gonzalez LC; François JC; Ly A; Trojan J
Adv Exp Med Biol; 2000; 465():319-32. PubMed ID: 10810636
[No Abstract] [Full Text] [Related]
14. Therapeutic applications of spherical nucleic acids.
Barnaby SN; Sita TL; Petrosko SH; Stegh AH; Mirkin CA
Cancer Treat Res; 2015; 166():23-50. PubMed ID: 25895863
[TBL] [Abstract][Full Text] [Related]
15. Stereocontrolled Oligonucleotides for Nucleic Acid Therapeutics: A Perspective.
Meena ; Lemaitre MM
Nucleic Acid Ther; 2021 Feb; 31(1):1-6. PubMed ID: 33305971
[No Abstract] [Full Text] [Related]
16. Antisense oligonucleotides as therapeutic agents.
Alama A; Barbieri F; Cagnoli M; Schettini G
Pharmacol Res; 1997 Sep; 36(3):171-8. PubMed ID: 9367660
[TBL] [Abstract][Full Text] [Related]
17. Cancer therapy using oligonucleotide-based STAT3 inhibitors: will they deliver?
Kortylewski M; Nechaev S
Ther Deliv; 2014 Mar; 5(3):239-42. PubMed ID: 24592948
[No Abstract] [Full Text] [Related]
18. Oligonucleotide treatment of ras-induced tumors in nude mice.
Wickstrom E
Mol Biotechnol; 2001 May; 18(1):35-55. PubMed ID: 11439698
[TBL] [Abstract][Full Text] [Related]
19. [Antisense oligonucleotides: a new therapeutic approach].
Guinot P; Temsamani J
Pathol Biol (Paris); 1998 May; 46(5):347-54. PubMed ID: 9769897
[TBL] [Abstract][Full Text] [Related]
20. Locked nucleic acid: a potent nucleic acid analog in therapeutics and biotechnology.
Jepsen JS; Sørensen MD; Wengel J
Oligonucleotides; 2004; 14(2):130-46. PubMed ID: 15294076
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
